Is amitriptyline the devil's work?
|
Time to read 8 min
Free delivery on orders over €59 🚚
|
Time to read 8 min
Few medications polarize as much as antidepressants. For some, they are a true blessing and a proven remedy for depression, anxiety, and even chronic pain. Others, however, see one particular medication, the TCA amitriptyline, as "devil's stuff" that further complicates the daily lives of those affected with severe side effects, drowsiness, and weight gain.
We get to the bottom of the facts: How dangerous is amitriptyline really? Do the positive effects outweigh the side effects? What alternatives are there – perhaps even beyond pills and the like? Also included: The latest research findings on possible gentler remedies for depression, anxiety, and pain.
The antidepressant amitriptyline is prescribed for a wide range of symptoms, including depression, (head)pain, anxiety, and even sleep problems. Unfortunately, it has many, sometimes severe side effects.
Currently, more and more natural alternatives are coming into focus. Cannabidiol (CBD) is also being investigated in numerous studies regarding its possible effects on pain, sleep, and psychological symptoms. However, the existing evidence is not sufficient to generally recommend CBD as an alternative to approved medications like amitriptyline.
Amitriptyline has been one of the established drugs for the treatment of various diseases for many decades. Like any medication, it can cause side effects that vary individually. In parallel, research is investigating further treatment approaches, including cannabidiol (CBD). Although initial studies describe possible effects on certain symptoms, the current scientific evidence is not sufficient to classify CBD as an equivalent alternative to approved medicines. Anyone interested in supplementary or alternative treatment approaches should discuss them with their treating physician.
Amitriptyline belongs to the group of tricyclic antidepressants (TCAs). Today, amitriptyline is mainly used as amitriptyline hydrochloride, but it is commonly referred to simply as "amitriptyline." The medication is one of the oldest and best-researched antidepressants available. It was developed in the 1960s, and although more modern alternatives exist today, it is still frequently prescribed – especially in low doses for the treatment of chronic pain, sleep disorders, or anxiety.
Due to its mode of action, amitriptyline is a true all-rounder and is used in a wide range of situations. Doctors prescribe it for the treatment of depression, pain management (for chronic pain, e.g., due to fibromyalgia or neuropathic pain), tension headaches, and migraines.
Amitriptyline can also help with anxiety and panic or with sleep problems, especially when nocturnal rumination interferes with sleep. Amitriptyline is even sometimes used for irritable bowel syndrome to influence pain processing in the gut. (1)
The effect of amitriptyline is based on blocking the reuptake of certain neurotransmitters, specifically serotonin and norepinephrine, into nerve cells. Both substances play a crucial role in our mood, drive, and pain perception.
Serotonin in the brain is responsible for emotional stability, inner calm, and general well-being, while norepinephrine ensures that we feel motivated, focused, and energetic. Inhibiting the reuptake of these two substances means they remain longer in the synaptic cleft, the space between nerve cells where signals are transmitted. A higher concentration of norepinephrine and serotonin leads to a more stable mood and a reduction in negative thoughts.
However, many people take amitriptyline in low doses even if they are not depressed. This is because serotonin and norepinephrine also influence pain sensation and other processes via the nerve pathways of our spinal cord. The exact mechanism of action is still being investigated. It is known that it involves a complex interplay of various mechanisms that go beyond the classic antidepressant effect.
Sounds too good to be true, right? In fact, the use of amitriptyline is now viewed quite critically – by some patients, but also by doctors. Many patients report severe side effects after taking amitriptyline, especially in the first few weeks. They are very tired, run down, complain of dizziness and lightheadedness, and have difficulty concentrating.
Difficulty urinating and digestive issues are also quite common. A decrease in libido, weight gain, and skin rash are also not uncommon. In rare cases, amitriptyline can cause heart rhythm disturbances, especially at too high a dose or with existing heart conditions.
The cause of these side effects lies primarily in the fact that amitriptyline does not only act on serotonin and norepinephrine. It also affects other receptor systems in the nervous system, especially histamine, muscarinic, and alpha receptors. For many patients, the side effects subside with prolonged use – but by no means for all.
During pregnancy and breastfeeding, amitriptyline is only prescribed in exceptional cases (e.g., for severe depression (major depression)). The use of amitriptyline in the last trimester, in particular, can have negative effects on the unborn child.
In children and older people, amitriptyline is used with particular caution, as both groups are more sensitive to side effects. Especially in children, amitriptyline is very rarely prescribed, for example, for chronic pain or severe sleep disorders. The data available is simply not sufficient to accurately assess efficacy and safety.
Especially here, dosages must start very low and be closely monitored, mainly due to the risk of cardiac arrhythmias and side effects such as drowsiness or concentration problems. Older people are also more sensitive, especially to sedative and anticholinergic effects that can increase the risk of falls or destabilize blood pressure.
However, amitriptyline is also not suitable for many other people. It is all the more important for doctors and pharmacists to know alternatives that can work just as well against pain and depression as TCAs.
CBD, short for cannabidiol, is a non-psychoactive substance from the hemp plant – unlike the well-known THC, CBD does not get you high. It works through the so-called endocannabinoid system in the body, which regulates numerous processes, including mood, sleep, pain perception, and inflammatory reactions.
Numerous preclinical and initial clinical studies suggest that CBD can have an anxiolytic, mood-stabilizing, pain-inhibiting, and sleep-promoting effect – thus falling into a very similar area of application as amitriptyline.
Research in recent years has shown that CBD could play an important role in the treatment of mental illnesses. In animal models and smaller clinical studies, the substance was able to reduce symptoms such as depression, anxiety, and psychosis. (2, 3)
Even if the current data is not sufficient to consider it an equivalent alternative to conventional antidepressants: CBD is and remains a great hope for all who suffer from the side effects of amitriptyline and similar medications. Because the side effects of CBD are minimal.
Important: CBD can interact with certain medications, including tricyclic antidepressants, because it is metabolized by the liver. So please be sure to talk to your doctor or psychiatrist before taking CBD.
Other natural remedies and measures are also being intensively investigated. St. John's Wort is certainly the best-known herbal antidepressant. It also acts as a serotonin reuptake inhibitor and has proven very effective in studies for mild to moderate depression – often with fewer side effects than psychotropic drugs. (4) However, St. John's Wort itself has some side effects and interactions, especially with classic antidepressants.
Some time ago, another idea received great attention: it was found that polyunsaturated fatty acids, specifically the fatty acid EPA (eicosapentaenoic acid), could positively influence mood, have an anti-inflammatory effect, and reduce the risk of depressive episodes. (5) However, newer studies show that the effect is not sufficient to treat severe depression. Nevertheless, the approach remains a good complement to classic therapy.
Furthermore, numerous studies show that exercise, sleep hygiene, sufficient daylight, and mindfulness practices such as yoga or meditation have a decisive influence on psychological health. Regular physical activity naturally increases serotonin levels, reduces stress hormones, and improves sleep quality – and can help reduce the need for medication. (6)
CBD (Cannabidiol) is the main alternative to amitriptyline – it has an anxiolytic, mood-stabilizing, pain-inhibiting, and sleep-promoting effect, without severe side effects such as drowsiness, weight gain, or cardiac arrhythmias. Especially in cases of mild depression, sleep problems, or chronic pain, CBD shows good results in combination with exercise, mindfulness exercises, and psychotherapy.
Other options: St. John's wort (herbal antidepressant for mild to moderate depression), omega-3 fatty acids as a supportive measure, and non-medicinal approaches such as regular exercise, yoga, meditation, and sufficient daylight. Always consult a doctor before discontinuing amitriptyline or taking alternatives.
CBD (Cannabidiol) is the most promising natural alternative to amitriptyline. The non-psychoactive substance from the hemp plant works through the endocannabinoid system as an anxiolytic, mood-stabilizing, pain-inhibiting, and sleep-promoting agent – thus in a similar area of application as amitriptyline, but with minimal side effects. Studies show efficacy in depression, anxiety, chronic pain, and sleep problems.
The best herbal antidepressants are CBD (Cannabidiol) – anxiolytic, mood-stabilizing, pain-inhibiting, and sleep-promoting with minimal side effects – and St. John's wort (Hypericum perforatum), the most established herbal antidepressant with proven efficacy in mild to moderate depression through serotonin reuptake inhibition. Omega-3 fatty acids (EPA) have anti-inflammatory and mood-lifting effects as a good therapeutic supplement.
Sources and Studies
(1) Update S3 guideline Irritable Bowel Syndrome: Definition, pathophysiology, diagnostics, and therapy. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM) (AWMF registration number 021/016). Zeitschrift für Gastroenterologie, 59(12), 1323-1415.
(2) García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020). Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. Biomolecules, 10(11), 1575.
(3) Guldager, M. B., Chaves Filho, A. M., Biojone, C., & Joca, S. (2024). Therapeutic potential of cannabidiol in depression. International review of neurobiology, 177, 251–293.
(4) Kholghi, G., Arjmandi-Rad, S., Zarrindast, M. R., & Vaseghi, S. (2022). St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?. Naunyn-Schmiedeberg's archives of pharmacology, 395(6), 629–642.
(5) Serefko, A., Jach, M. E., Pietraszuk, M., Świąder, M., Świąder, K., & Szopa, A. (2024). Omega-3 Polyunsaturated Fatty Acids in Depression. International journal of molecular sciences, 25(16), 8675.
(6) Pearce, M., Garcia, L., Abbas, A., Strain, T., Schuch, F. B., Golubic, R., Kelly, P., Khan, S., Utukuri, M., Laird, Y., Mok, A., Smith, A., Tainio, M., Brage, S., & Woodcock, J. (2022). Association Between Physical Activity and Risk of Depression: A Systematic Review and Meta-analysis. JAMA psychiatry, 79(6), 550–559.